The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 11, Pages 3196
Publisher
MDPI AG
Online
2021-05-27
DOI
10.3390/molecules26113196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia
- (2021) Tiago M. Guimarães et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Treatment-resistant schizophrenia – A RCT on the effectiveness of repeated-dose sodium nitroprusside
- (2021) Marcelo P.M. Adelino et al. SCHIZOPHRENIA RESEARCH
- Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study
- (2020) Kate Merritt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia
- (2020) SeungJu Jackie Oh et al. SCHIZOPHRENIA RESEARCH
- Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia
- (2019) Hannah E. Brown et al. JAMA Psychiatry
- Effects of sodium nitroprusside in the acute dizocilpine (MK-801) animal model of schizophrenia
- (2019) Xiujuan Wang et al. BRAIN RESEARCH BULLETIN
- Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats
- (2019) Joep Titulaer et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain
- (2018) Mariana C. Diana et al. CNS Neuroscience & Therapeutics
- The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds
- (2018) Ana Carolina Issy et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial
- (2018) Xiujuan Wang et al. PSYCHIATRY RESEARCH
- Epigenetics: The third pillar of nitric oxide signaling
- (2017) Samantha Socco et al. PHARMACOLOGICAL RESEARCH
- The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia
- (2016) Nikolaos Pitsikas CURRENT MEDICINAL CHEMISTRY
- The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
- (2016) J. M. Stone et al. PSYCHOLOGICAL MEDICINE
- MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside
- (2016) Jessica L. Hurtubise et al. PSYCHOPHARMACOLOGY
- The role of nitric oxide in the object recognition memory
- (2015) Nikolaos Pitsikas BEHAVIOURAL BRAIN RESEARCH
- Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
- (2015) Ludmyla Kandratavicius et al. BMC NEUROSCIENCE
- The Effects of Sodium Nitroprusside Treatment on Cognitive Deficits in Schizophrenia
- (2015) Joao Paulo Maia-de-Oliveira et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats
- (2015) Aikaterini Trevlopoulou et al. PSYCHOPHARMACOLOGY
- Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week
- (2015) Joao Paulo Maia-de-Oliveira et al. SCHIZOPHRENIA RESEARCH
- Nitric Oxide Donors as Neuroprotective Agents after an Ischemic Stroke-Related Inflammatory Reaction
- (2013) Marisol Godínez-Rubí et al. Oxidative Medicine and Cellular Longevity
- Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice
- (2013) Ana C. Issy et al. PSYCHOPHARMACOLOGY
- Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside
- (2013) Jaime E. C. Hallak et al. JAMA Psychiatry
- Nitric Oxide and Schizophrenia: Present Knowledge and Emerging Concepts of Therapy
- (2012) Hans-Gert Bernstein et al. CNS & Neurological Disorders-Drug Targets
- Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
- (2012) Judith Pratt et al. NATURE REVIEWS DRUG DISCOVERY
- Nitric oxide modulates apomorphine-induced recognition memory deficits in rats
- (2012) Ioannis Gourgiotis et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI
- (2011) Amy Pinkham et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Targeting glutamate synapses in schizophrenia
- (2011) Julie R. Field et al. TRENDS IN MOLECULAR MEDICINE
- Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study
- (2010) Yuichiro Nakano et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Schizophrenia: The drug deadlock
- (2010) Alison Abbott NATURE
- The environment and schizophrenia
- (2010) Jim van Os et al. NATURE
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cingulate White Matter Neurons in Schizophrenia and Bipolar Disorder
- (2009) Caroline M. Connor et al. BIOLOGICAL PSYCHIATRY
- Pharmacological Modulation of Nitric Oxide Release: New Pharmacological Perspectives, Potential Benefits and Risks
- (2009) R. Scatena et al. CURRENT MEDICINAL CHEMISTRY
- Hyperdopaminergic Tone Erodes Prefrontal Long-Term Potential via a D2 Receptor-Operated Protein Phosphatase Gate
- (2009) T.-X. Xu et al. JOURNAL OF NEUROSCIENCE
- Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats
- (2009) Larissa de Oliveira et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls
- (2008) Bun-Hee Lee et al. SCHIZOPHRENIA RESEARCH
- Recent developments in nitric oxide donor drugs
- (2007) M R Miller et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started